Linda is a 39yo premenopausal white female diagnosed with right breast cancer
Only 9 months after diagnosis and treatment, there was evidence of recurrence with bone pain
Computed tomography found multiple bone metastases and interstitial infiltrates in right lung
Case #2: Advanced Prostate Cancer
Max is a 79yo white male diagnosed with prostate cancer
Patient experiences hypersensitivity reaction during docetaxel infusion
He later complains of nausea, possibly related to either chemotherapy or hyperglycemia secondary to corticosteroids
Program Two
Case #1: HER2-Positive Breast Cancer
Susan is a 65yo married black female with stage IIB breast cancer
After 4th cycle of chemotherapy, patient complains of hair loss, nausea, and increased fatigue
Case #2: Unresectable Non-Small Cell Lung Cancer
Robert is a 72yo Hispanic married male, reports 1 drink per night, and 40-year smoking history
Diagnosed with inoperable stage IIIA NSCLC
After 4th cycle, patient develops grade 2/3 neurotoxicity (peripheral neuropathy)
Program Three
Case #1: Resectable Non-Small Cell Lung Cancer
Janet is a 54yo white female smoker (>30 years)
Wedge resection revealed a 4.5 cm non-small cell lung cancer (NSCLC)
During cycle 1 of docetaxel, patient’s absolute neutrophil count was 750 cells/mm(3)on day 8
Case #2: Hormone Refractory Prostate Cancer
Stephen is a 65yo black male with metastatic adenocarcinoma of the prostate
Chemotherapy started after hormone therapy was unsuccessful
Complains of nausea, hair loss, sexual dysfunction, vasomotor symptoms, and mild neuropathy
Agenda
Registration and Dinner
Introduction and Program Overview
First Case*
Video Case Presentation/Didactic Slide Presentation/ Breakout Interactive Session
Second Case*
Video Case Presentation/Didactic Slide Presentation/ Breakout Interactive Session Question & Answer Session Program Conclusion
*Cases to be determined by audience upon registration. The most requested program for each meeting will be presented.
Statement of Need
Taxanes are highly effective chemotherapy agents and have become a cornerstone in breast cancer treatment. They are also used as standard therapy and provide clinical benefit for non-small cell lung cancer (NSCLC), and metastatic hormone-refractory prostate cancer (HRPC). Despite their high degree of efficacy, adverse events do occur. Oncology nurses and Advanced Practice Nurses (APNs) are intimately involved in the care of patients with cancer. They administer medications, manage side effects during infusion and after treatment, and provide psychosocial\support. Oncology nurses and APNs should understand the rationale for treatment and expected toxicities and develop individualized clinical management strategies. To this end, education is imperative to improve patient care through the identification and prevention of adverse events and the education of patients and families to make informed treatment decisions.
